What happened with AUNA today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Auna S.A.’s hospitals, clinics and outpatient facilities focus on complex care, including cancer treatment, heart care and neurological procedures. Healthcare services generate most of its revenue. Insurers and institutional payers pay for nearly all facility revenue in Mexico and Colombia; Peru has a larger mix of patients paying directly and payments from Auna’s own plans. Auna negotiates reimbursement prices and inclusion in insurers’ approved hospital networks, which helps determine how many patients its facilities receive.
In Peru, Oncosalud sells prepaid cancer coverage and provides virtually all covered diagnostics and treatment through the same company. Members generally pay monthly for coverage under an annual contract. Auna also sells general healthcare plans in Peru and dental, vision and cancer insurance through Auna Seguros in Mexico. These plans bring in fees before care is delivered, but Auna bears the cost of covered treatment and cannot raise plan prices during the contract year to recover unexpectedly high costs.
The business depends on keeping facilities busy, attracting doctors and controlling treatment costs. In Mexico, unaffiliated doctors generate substantially all facility-service revenue and have no obligation to treat patients there. In Colombia, Auna relies heavily on EPS health insurers for reimbursement, with financial distress and payment delays affecting collections. Facilities need government licenses to operate, while prepaid plans in Peru must meet capital and investment rules.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Auna’s results depend chiefly on hospital utilization and insurer reimbursement in Mexico, Peru and Colombia, plus oncology-plan membership and treatment costs in Peru—not on a close regional rival in this list.
Starling Oncology’s supplied TOI business offers a parallel for Auna’s exposure to cancer-treatment demand and costs: TOI delivers care in the United States under contracts that share treatment-cost risk with healthcare payers, while Auna sells prepaid oncology plans and provides treatment in Peru. Watch TOI’s costs under those contracts as a comparison for Auna’s treatment costs relative to plan revenue, not as a readout of local competition.
Auna S.A. earningsThis company
Auna's report will show whether revenue growth in its Peru prepaid plans and healthcare services is turning into profit and cash.
Read Oncosalud Peru's plan revenue alongside Healthcare Services in Peru, then check consolidated operating profit and cash from operations. Some services are provided to Oncosalud Peru within the group, so the two segment revenues are not all separate outside sales. If both businesses grow while operating profit and cash generation hold up, plan fees and care delivery are supporting profitable growth that brings in cash; if revenue rises but margins or cash flow weaken, care costs or slower collections may be eating into that growth.
